Sepsis: Transform
Risk Stratification
at the bedside

A deadly and costly crisis

Common

~1 in 3 patients who die in the hospital have sepsis1

Costly

#1 inpatient cost in US hospitals, totaling >$27 billion/year2

Consequential

Leading cause of US in-hospital mortality, up to 70% in patients with septic shock3,4

Sepsis mortality — one hour makes all the difference

An updated, evidence-based bundle from the Surviving Sepsis Campaign (SSC), released in 2018, emphasizes expediency of care to improve survival.

2018 SSC Hour-1 Bundle:
Measure lactate level. Re-measure if initial lactate is >2 mmol/L 
Obtain blood cultures prior to administration of antibiotics 
Administer broad-spectrum antibiotics 
Rapidly administer 30 ml/kg crystalloid for hypotension or lactate ≥4 mmol/L 
Apply vasopressors if patient is hypotensive during or after fluid resuscitation to maintain MAP ≥65 mm Hg 
  • Lactate-guided resuscitation is associated with significantly reduced mortality5
  • Yet only 53% of clinicians order lactate with blood culture for patients with sepsis4
  • When lactate is ordered, long turnaround times have been identified as a barrier to bundle compliance4

8%

Every hour sepsis treatment is delayed, risk of death increases by up to 8%5
Solutions

i-STAT CG4+ — Expediting Risk Stratification to optimize acuity-based care

When every minute counts, i-STAT CG4+ improves care team efficiency, coordination, and communication─quickly guiding resources to those who need it most.

In clinical studies, i-STAT CG4+ has been shown to significantly improve ED efficiency and quality.

  • Reduced door-to-lactate result time by 72%6
  • Reduced ED care time (arrival-to-disposition decision) by 11%7 
  • Provided a cost-effective means to identify patients benefitting from early resuscitation8
Want more information about how your organization
can achieve sepsis care transformation?

Request more info

References

1. CDC Sepsis Fact Sheet.
2. Sepsis Alliance Website.  www.sepsis.org
3. Sepsis Alliance Sepsis Fact Sheet.
4. Advisory Board Sepsis Research Report.
5. Levy MM, Evans LE, Rhodes A.
6. Singer AJ, Taylor M, LeBlanc D et al. 2014.
7. Singer AJ, Taylor M, LeBlanc D et al. 2018.
8. Ward MJ, Self WH, Singer A et al.

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

Not optimized for your device

The page you are trying to access is best viewed on a desktop or laptop computer.

I want to view this page anyway
Contact us today